← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lisata Therapeutics Inc
Basking Ridge, NJ
$6,150,295
Total funding
9
Grants
Funding over time
peak $1.6M · FY2009–19$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,849,337 · 7
DOD$2,300,958 · 2
By mechanism
R44$2,353,076 · 2
—$2,300,958 · 2
R43$851,763 · 3
R01$344,498 · 1
N43$300,000 · 1
Investigators at Lisata Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF AUTOLOGOUS PLURIPOTENT VERY SMALL EMBRYONIC-LIKE STEM CELLS (VSELS) TO TREAT OSTEOPOROSIS$1,639,544
· FY2011 · Department of Defense
Exploratory Clinical Study to Evaluate the Potential Bioactivity of CLBS14 in Patients with Coronary Microvascular Dysfunction$973,475
R44 · FY2018 · HL
Exploratory Clinical Study to Evaluate the Potential Bioactivity of CLBS14 in Patients with Coronary Microvascular Dysfunction$753,565
R44 · FY2017 · HL
THE USE OF TOPICALLY APPLIED BONE MARROW-DERIVED ADULT MESCENCHYMAL STEM CELLS (MSCS) FOR RAPID WOUND HEALING.$661,414
· FY2010 · Department of Defense
Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic lik$411,776
R44 · FY2012 · DE
3D retina-RPE constructs for vision restoration in new retinal degeneration m$344,498
R01 · FY2015 · EY
Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) s$300,000
R43 · FY2013 · AI
IGF::OT::IGF DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS$300,000
N43 · FY2015 · CA
Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) s$295,252
R43 · FY2012 · AI
Exploratory Clinical Study To Evaluate The Potential Bioactivity Of CLBS16 In Patients With Coronary Microvascular Dysfunction$214,260
R44 · FY2019 · HL
Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to T$147,765
R43 · FY2013 · AR
Repair of boney defects by human stem cells$108,746
R43 · FY2009 · AR